US-Listed China Biotechs Tank As Xi Takes Third Term

Uncertainties And Risks Seen Rising

 
• By Brian Yang
  
US-LISTED CHINESE BIOTECHS NOSEDIVE ON UNCERTAINTIES FROM NEW CHINA LEADERSHIP • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia